Preferred Label : EGF Receptor Downregulation by CBL Pathway;
NCIt related terms : CBL mediated ligand-induced downregulation of EGF receptors;
Alternative definition : BIOCARTA: As with many cell-surface receptors, activation of the EGF receptor can
result in receptor internalization through receptor-mediated endocytosis, desensitizing
further receptor signaling. This process requires clathrin and occurs in clathrin-coated
pits, which pinch off from the plasma membrane to form vesicles that move to the early
endosome. From the early endosome, receptors can either be recycled back to the cell
surface, or they can move through the late endosome to the lysosome for proteolytic
degradation. The sorting of receptors in the early endosome for degradation requires
the tyrosine kinase activity of activated growth factor receptor and involves ubiquitination
of the receptor. Targeting of receptors for degradation requires members of the Cbl
gene family. Cbl proteins bind to tyrosine phosphorylated EGF receptor, and are E3
ubiquitination ligases that label receptor for degradation. Cbl also recruits Cin85
to the receptor complex, and blocking Cin85 interaction blocks receptor internalization
and degradation. Endophilins are also a member of this receptor-bound protein complex.
In its role as a ubiquitin ligase and docking protein, Cbl desensitizes EGF signaling
and also opposes cellular proliferation induced by EGF. EGF activation also appears
to activate the tyrosine kinase Src, which phosphorylates Cbl, and helps to activate
the ubiquitination and degradation of EGF receptor. PKC activation and threonine phosphorylation
of the EGF receptor can induce heterologous receptor internalization, but opposes
Cbl-mediated receptor degradation. PKC phosphorylated receptors are sorted for recycling
to the cell surface, and directed away from the late endosome and proteasome. Other
growth factor receptors are regulated in a similar manner, including the PDGF receptor,
HGF receptor and the CSF-1 receptor, indicating that this is a fairly general regulatory
mechanism. The importance of Cbl in the down-regulation of growth factor signaling
means that it will have an important role in cellular transformation and the development
and treatment of cancer. (This definition may be outdated - see the DesignNote.);
NCIt note : The BIOCARTA Definition (ALT_DEFINITION) for this pathway concept was provided by
BioCarta. This property was not created by, nor is it maintained by the NCI Thesaurus
staff. Additionally, BioCarta is no longer updating its pathway data; thus, the BIOCARTA
Definition might be outdated or inaccurate. Please see the Terms and Conditions for
Use at http://www.biocarta.com/.;
Biocarta ID : h_cblPathway;
Origin ID : C39016;
UMLS CUI : C1512119;
Semantic type(s)
has_gene_product_element
pathway_has_gene_element